Nootropic Focus
84
sintesi
2
1,000
intermediate
May 17, 2026
Panoramica
The Nootropic Focus stack combines two Russian-developed neuropeptides that operate through complementary mechanisms to enhance cognitive performance while reducing anxiety. Semax is a synthetic analog of ACTH(4-10) — the fragment of adrenocorticotropic hormone responsible for its cognitive effects without the adrenal-stimulating properties. Semax increases brain-derived neurotrophic factor (BDNF) expression by 3-4x in the hippocampus and prefrontal cortex, promotes nerve growth factor (NGF) synthesis, and modulates dopaminergic and serotonergic neurotransmission. In Russian clinical use since 1994, it is prescribed for cognitive impairment, stroke recovery, and optic nerve atrophy. Selank is a synthetic analog of the naturally occurring immunomodulatory peptide tuftsin, with an additional Pro-Gly-Pro sequence that increases its stability and CNS penetration. Selank''s primary mechanism involves modulation of the GABAergic system — it acts as an anxiolytic without the sedation, cognitive impairment, or addiction potential of benzodiazepines. It also influences the expression of BDNF and enkephalins, creating a calm-but-focused mental state rather than the wired alertness of stimulants. The synergy between Semax and Selank is particularly elegant for cognitive enhancement: Semax provides the "drive" component — increased BDNF, enhanced dopaminergic tone, improved attention and working memory — while Selank provides the "calm" component — reduced anxiety, stabilized mood, and prevention of the stress response that impairs prefrontal function. Together they create a state of relaxed concentration ideal for demanding cognitive work. Both are administered nasally for direct access to the CNS via the olfactory epithelium, bypassing the blood-brain barrier. The nasal route provides onset within 5-15 minutes and duration of 4-6 hours.
Protocollo di Dosaggio
600 mcg
per dose
400 mcg
per dose
Obiettivi & Evidenze
Avvertenze
- Semax and Selank are approved medications in Russia. Not FDA-approved in US. Available as research peptides. Both have good safety profiles in clinical use.
Comments
Sign in to join the discussion
Avvertenza: Questo stack è compilato dalla comunità e a scopo di ricerca solo. Peptide Contacts non verifica la sicurezza o l'efficacia dei stack compilati. Consulta sempre un professionista sanitario qualificato prima di utilizzare qualsiasi protocollo di peptidi.